← FDA Drug Approvals (Drugs@FDA)
EXSERVAN
NDA · New Drug Application · Sponsor: AQUESTIVE · Approved 2019-11-22
Drug application
- FDA Application #
NDA212640- Application type
- New Drug Application
- Brand name
- EXSERVAN
- Generic name
- Riluzole
- Active ingredients
- RILUZOLE
- Dosage form
- FILM
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- AQUESTIVE
- First approval
- 2019-11-22
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown